Pharmaceutical Industry Report

7/23/2019 Pharmaceutical Industry Report

1/52

Table of Contents

A. Company Certificate

B. Declaration ............... (i)

C. Acknowledgment ..... (ii)

D. Preface...................................................................................... (iii)

E. Execti!e "mmary . (i!)

#. C$APTE% #& 'ntrodction.. *

1.1. Overview of the Industry. 3

1.1.1. Pharmaceutical Industry in India

1.. Com!any Profile.. "

1..1. A#out the Com!any

1... $ission

1..3. %ision

1..&. Our '!eciali(ation

1..&.1. Ayurvedic ) *er#al Products

1..&.. +utraceutical !roducts1..,. Our 'ervices

1..-. Our $anufacturin Process

1.3. Orani(ation 'tructure .. 3-

1.&. /lim!se of our clients ...................................................30

+. C$APTE% +& 'ntrodction to Pro,ect ..- -

. C$APTE% & Conceptal Discssion.....-- -/

3.1. *ow Business Develo!ment taes !lace in Pharma Com!any

-. C$APTE% -& "01T Analysis... -2 -3

/. C$APTE% /& 4a,or C5allenges faced by t5e 'ndstry ....... -6 -*

2. C$APTE% 2& Appendix 7 8ibliograp5y / /#

1


2/52

1!er!iew of t5e 'ndstry

The Indian Pharmaceutical industry is a success story providing employment

for millions and ensuring that essential drugs at affordable prices areavailable to the vast population of this sub-continent.

2ichard /erster

P5armacetical 'ndstry in 'ndia

he Pharmaceutical industry in India is the world4s third5larest in terms of

volume and stands 1&th in terms of value.

he Indian !harmaceutical industry currently to!s the chart amonst India4s

science5#ased industries with wide ranin ca!a#ilities in the com!le6 field of

dru manufacture and technoloy. A hihly orani(ed sector7 the Indian

!harmaceutical industry is estimated to #e worth 8 &., #illion7 rowin at

a#out 9 to " !ercent annually. It rans very hih amonst all the third world

countries7 in terms of technoloy7 :uality and the vast rane of medicines that

are manufactured. It ranes from sim!le headache !ills to so!histicated

anti#iotics and com!le6 cardiac com!ounds7 almost every ty!e of medicine is

now made in the Indian !harmaceutical industry. he Indian !harmaceutical

sector is hihly framented with more than ;7;;; reistered units. It has

e6!anded drastically in the last two decades. he Pharmaceutical and

Chemical industry in India is an e6tremely framented maret with severe

!rice com!etition and overnment !rice control. he Pharmaceutical industry

in India meets around 0;< of the country4s demand for #ul drus7 dru

intermediates7 !harmaceutical formulations7 chemicals7 ta#lets7 ca!sules7 orals

and in=ecti#les. here are a!!ro6imately ,; lare units and a#out 9;;; 'mall

'cale >nits7 which form the core of the !harmaceutical industry in India

?includin , Central Pu#lic 'ector >nits@. he /overnment has also !layed a

vital role in the develo!ment of the India 'oftware Industry. In 1"9-7 the

Indian overnment announced a new software !olicy which was desined to

serve as a catalyst for the software industry. his was followed in 1"99 with

2


3/52

the orld $aret Policy and the esta#lishment of the 'oftware echnoloy

Pars of India ?'P@ scheme. In addition7 to attract forein direct investment7

the Indian /overnment !ermitted forein e:uity of u! to 1;; !ercent and duty

free im!ort on all in!uts and !roducts.

Crrent "cenario he industry has enormous rowth !otential. actors listed

#elow determine the risin demand for !harmaceuticals.

he rowin !o!ulation of over a #illion.

Increasin income.

Demand for :uality healthcare service.

Chanin lifestyle has led to chane in disease !atterns7 and

increased demand for new medicines to com#at lifestyle related

diseases.

$ore than 9, !er cent of the formulations !roduced in the country are sold in

the domestic maret. India is larely self5sufficient in case of formulations.

'ome life savin7 new eneration under5!atent formulations continue to #e

im!orted7 es!ecially #y $+Cs7 which then maret them in India. Overall7 the

si(e of the domestic formulations maret is around 2s1-; #illion and it is

rowin at 1; !er cent !er annum.

3


4/52

Demand for drus for treatment of lifestyle5related diseases such as dia#etes7

cardiovascular diseases7 and central nervous system are on the increase. here

are around 0;;7;;; new cases of cancer each year and total of around .,

million cases. It is estimated that there are around &; million !eo!le in India

with dia#etes and the num#er is risin7 ,.1 million. *I%)AID' !atients7 and 1&

million tu#erculosis cases. Accordin to industry re!orts7 while the Indian

!harmaceutical industry witnessed a rowth of 0 !ercent7 the cardio5vascular

sement recorded 1, to 10 !ercent rowth and anti5dia#etes sement of over

1;51 !ercent rowth.

Diagnostic 1tsorcing9 Clinical Trails the Indian dianostic services are

!ro=ected to row at a CA/2 of more than ; !er cent durin ;1;5;1.

'ome of the ma=or Indian !harmaceutical firms7 includin 'un Pharma7

Cadilla *ealthcare and Piramal ife 'ciences7 had a!!lied for conductin

clinical trials on at least 1 new drus in ;1;7 indicatin a rowin interest in

new dru discovery research.

:enerics India to!s the world in e6!ortin eneric medicines worth >'8 11

#illion and currently7 the Indian !harmaceutical industry is one of the world4s

larest and most develo!ed. $oreover7 the Indian eneric dru maret to row

at a CA/2 of around 10 !er cent #etween ;1;511 and ;1513. >nion

$inister of Commerce and Industry and $inister for rade and Industry7

'ina!ore7 have sined a 4'!ecial 'cheme for 2eistration of /eneric

$edicinal Products from India4 in $ay ;1;7 which sees to fast5trac the

reistration !rocess for Indian eneric medicines in 'ina!ore.

Ad!antage 'ndia he Indian Pharmaceutical Industry7 !articularly7 has #een

the front runner in a wide rane of s!ecialties involvin com!le6 drus4

manufacture7 develo!ment and technoloy. ith the advantae of #ein a

hihly orani(ed sector7 the !harmaceutical com!anies in India are rowin at

the rate of 8 &., #illion7 reisterin further rowth of 9 5 " < annually. $ore

than ;7;;; reistered units are framented across the country and re!orts say

that ,; leadin Indian !harmaceutical com!anies control 0;< of the maret

share with star !rice com!etition and overnment !rice reulations.

4


5/52

Competent workforce:India has a !ool of !ersonnel with hih manaerial and

technical com!etence as also silled worforce. It has an educated wor force

and Enlish is commonly used. Professional services are easily availa#le.

Cost-effective chemical synthesis: Its trac record of develo!ment7

!articularly in the area of im!roved cost5#eneficial chemical synthesis for

various dru molecules is e6cellent. It !rovides a wide variety of #ul drus

and e6!orts so!histicated #ul drus.

Legal & Financial Framework:India has a ,3 year old democracy and hence

has a solid leal framewor and stron financial marets. here is already an

esta#lished international industry and #usiness community.

Information &Technology:It has a ood networ of world5class educational

institutions and esta#lished strenths in Information echnoloy.

Globalization: he country is committed to a free maret economy and

lo#ali(ation. A#ove all7 it has a 0; million middle class maret7 which is

continuously rowin.

Consoliation: or the first time in many years7 the international

!harmaceutical industry is findin reat o!!ortunities in India. he !rocess of

consolidation7 which has #ecome a enerali(ed !henomenon in the world

!harmaceutical industry7 has started tain !lace in India.

he overnment started to encourae the rowth of dru manufacturin #y

Indian com!anies in the early 1"-;s7 and with the Patents Act in 1"0;.

*owever7 economic li#erali(ation in ";s #y the former Prime 4inister P.;.

Dr. 4anmo5an "ing5

ena#led the industry to #ecome what it is today. his !atent act removed

com!osition !atents from food and drus7 and thouh it e!t !rocess !atents7

these were shortened to a !eriod of five to seven years.

5


6/52

he lac of !atent !rotection made the Indian maret undesira#le to the

multinational com!anies that had dominated the maret7 and while they

streamed out. Indian com!anies carved a niche in #oth the Indian and world

marets with their e6!ertise in reverse5enineerin new !rocesses for

manufacturin drus at low costs. Althouh some of the larer com!anies

have taen #a#y ste!s towards dru innovation7 the industry as a whole has

#een followin this #usiness model until the !resent.

he Indian !harmaceutical sector has come a lon way7 #ein almost non5

e6istent #efore 1"0; to a !rominent !rovider of healthcare !roducts7 meetin

almost ", !er cent of the country4s !harmaceuticals needs. he Industry today

is in the front ran of Indias science5#ased industries with wide ranin

ca!a#ilities in the com!le6 field of dru manufacture and technoloy. It rans

very hih in the third world7 in terms of technoloy7 :uality and rane of

medicines manufactured. rom sim!le headache !ills to so!histicated

anti#iotics and com!le6 cardiac com!ounds7 almost every ty!e of medicine is

now made indienously.

Playin a ey role in !romotin and sustainin develo!ment in the vital field

of medicines7 Indian Pharma Industry #oasts of :uality !roducers and many

units a!!roved #y reulatory authorities in >'A and >F. International

com!anies associated with this sector have stimulated7 assisted and

s!earheaded this dynamic develo!ment in the !ast ,3 years and hel!ed to !ut

India on the !harmaceutical ma! of the world.

he Indian Pharmaceutical sector is hihly framented with more than ;7;;;

reistered units with severe !rice com!etition and overnment !rice control. It

has e6!anded drastically in the last two decades. here are a#out ,; lare

units that control 0; !er cent of the maret with maret leader holdin nearly 0

!er cent of the maret share and a#out 9;;; 'mall 'cale >nits toether which

form the core of the !harmaceutical industry in India ?includin , Central

Pu#lic 'ector >nits@. hese units !roduce the com!lete rane of

!harmaceutical formulations7 i.e.7 medicines ready for consum!tion #y

6


7/52

!atients and a#out 3,; #ul drus7 i.e.7 chemicals havin thera!eutic value and

used for !roduction of !harmaceutical formulations.

ollowin the de5licensin of the !harmaceutical industry7 industrial licensin

for most of the drus and !harmaceutical !roducts has #een done away with.

$anufacturers are free to !roduce any dru duly a!!roved #y the Dru

Control Authority. echnoloically stron and totally self5reliant7 the

!harmaceutical industry in India has low costs of !roduction7 low 2GD costs7

innovative scientific man!ower7 strenth of national la#oratories and an

increasin #alance of trade.

he num#er of !urely Indian !harma com!anies is fairly low. Indian !harma

industry is mainly o!erated as well as controlled #y dominant forein

com!anies havin su#sidiaries in India due to availa#ility of chea! la#or in

India at lowest cost. $ost !harma com!anies o!eratin in India7 even the

multinationals7 em!loy Indians almost e6clusively from the lowest rans to

hih level manaement. $irrorin the social structure7 firms are very

hierarchical. *omerown !harmaceuticals7 lie many other #usinesses in

India7 are often a mi6 of !u#lic and !rivate enter!rise. Althouh many of these

com!anies are !u#licly owned7 leadershi! !asses from father to son and the

foundin family holds a ma=ority share.

he total Indian !roduction constitutes a#out 13 !er cent of the world maret

in value terms and7 9 !er cent in volume terms. he !er ca!ita consum!tion of

drus in India7 stands at >'837 is amonst the lowest in the world7 as

com!ared to Ha!an5 >'8&17 /ermany5 >'8 and >'A5 >'81"1.

7


8/52

A81?T T$E C14PA


9/52

dilience of the entire team has yielded #rilliant results and has hel!ed us

flourish as a !rofound name in the *er#al)Ayurveda industry. It is one of the

few manufacturin !lant which #lend modern !roduction technoloy and

advanced :uality measures into the area of *er#al) Ayurveda healthcare

medicines and nutraceutical. On the commercial front7 we have !resented

many new dimensions in !acin7 which is still not very !revalent in Ayurveda

Industry7 e.. AlBAlfacility with JPrint 2eistration ControlK feature7 $et5

!at finish !roducts etc.

Companys 4ission&

e want to offer !roducts of hihest :uality standards at the most com!etitive

!rices in India. e are on a never endin research7 develo!ment and

manufacturin of a #road s!ectrum of *er#al) Ayurvedic and nutraceutical

!roducts and thrivin to fulfill the needs of our valued customers in terms of

!roduct rane7 :uality7 efficacy7 safety and !rice.

Companys ;ision&

e as!ire to wor on our consistent self5im!rovisin mind5set and #e the #est

manufacturer and su!!lier of hih :uality *er#al) Ayurvedic and +utraceutical

!roducts in the country. e also aim at satisfaction and relia#ility of our

associates for :uality and !urity of the !roduct for lifetime.

1r "pecialiation&

I. Ayr!edic 9 $erbal Prodcts

he Ayurveda medicinal system was #ased on her#s which are taen forward

in formin the her#al medicines. hese her#al medicines includes her#s7

her#al materials7 her#al !re!aration G finished her#al !roducts that contains as

active inredients !arts of !lants or other !lant materials or com#ination.

9


10/52

II.


11/52

I. Ayr!edic 9 $erbal Prodcts

Ayurvedic !roducts are of two ty!esL

1. *er#al $edicinal

. *er#al Cosmetics

1. $erbal 4edicinal Prodcts

'ome !lants contain su#stances that may #e used to treat diseases.

$edicinal !roducts that are made from these su#stances are nown as Mher#al

medicinal !roductsM. Even thouh they are natural7 a num#er of these !roducts

may #e danerous for !atients. his is why they are covered #y!harmaceutical leislation7 which aims to !rotect !u#lic health #y ensurin the

safety7 efficacy and :uality of medicinal !roducts. ithin the rou! of her#al

medicinal !roducts7 some have a lon tradition of use.

'ome e6am!les of her#als used in traditional her#al medicinal !roducts areL

Calendula officinalis N Echinacea !ur!urea .7 $oenchN

Eleutherococcussenticosus ?2u!r. Et $a6im.@ $a6iN oeniculumvulare

$iller su#s!. vulare var. vulareN oeniculumvulare $iller su#s!. vulare

var. dulce ?$iller@ hellunN *amamelisviriniana N $entha 6 !i!erita . and

Pim!inellaanisum .

A her#al !roduct will #e considered a medicinal !roduct where !resented as

havin !ro!erties for treatin or !reventin disease in human #eins or where

it has a !harmacoloical7 immunoloical or meta#olic action. It is the

com!etence and res!onsi#ility of national authorities to decide7 on a case5#y5

case #asis7 whether a her#al !roduct fulfills the definition of medicinal

!roduct.

*owever7 her#al !roducts may #e classified and !laced on the maret as food

!rovided that they do not fulfill the definition of medicinal !roducts and that

they do com!ly with the a!!lica#le food law. In !articular7 her#al !roducts

mareted in the form of food su!!lements should com!ly with Directive

11


12/52

;;)&-)EC on food su!!lements and 2eulation ?EC@ +o 1"&);;- on

nutrition and health claims made on foods.

Ad!antageshere are a num#er advantaes associated with usin her#al medicines as

o!!osed to !harmaceutical !roducts. E6am!les include the followinL

2educed ris of side effectsL $ost her#al medicines are well tolerated

#y the !atient7 with fewer unintended conse:uences than

!harmaceutical drus. *er#s ty!ically have fewer side effects than

traditional medicine7 and may #e safer to use over time.

Effectives with chronic conditionsL *er#al medicines tend to #e moreeffective for lon5standin health com!laints that don4t res!ond well to

traditional medicine. One e6am!le is the her#s and alternative

remedies used to treat arthritis. %io667 a well5nown !rescri!tion dru

used to treat arthritis7 was recalled due to increased ris of

cardiovascular com!lications. Alternative treatments for arthritis7 on

the other hand7 have few side effects. 'uch treatments include dietary

chanes lie addin sim!le her#s7 eliminatin veeta#les from the

nihtshade family and reducin white suar consum!tion.

ower costL Another advantae to her#al medicine is cost. *er#s cost

much less than !rescri!tion medications. 2esearch7 testin7 and

maretin add considera#ly to the cost of !rescri!tion medicines.

*er#s tend to #e ine6!ensive com!ared to drus.

ides!read availa#ilityL et another advantae of her#al medicines are

their availa#ility. *er#s are availa#le without a !rescri!tion. ou can

row some sim!le her#s7 such as !e!!ermint and chamomile7 at home.

In some remote !arts of the world7 her#s may #e the only treatment

availa#le to the ma=ority of !eo!le.

Disad!antages

*er#s are not without disadvantaes7 and her#al medicine is not

a!!ro!riate in all situations. hese are a few of the disadvantaes to

considerL

12


13/52

Ina!!ro!riate for many conditionsL $odern medicine treats sudden and

serious illnesses and accidents much more effectively than her#al or

alternative treatments. An her#alist would not #e a#le to treat serious

trauma7 such as a #roen le7 nor would he #e a#le to heal an

a!!endicitis or a heart attac as effectively as a conventional doctor

usin modern dianostic tests7 surery7 and drus.

ac of dosae instructionsL Another disadvantae of her#al medicine

is the very real riss of doin yourself harm throuh self5dosin with

her#s. hile you can arue that the same thin can ha!!en with

medications7 such as accidentally overdosin on cold remedies7 many

her#s do not come with instructions or !acae inserts. here4s a very

real ris of overdose.

Poison ris associated with wild her#sL *arvestin her#s in the wild is

risy7 if not foolhardy7 yet some !eo!le try to identify and !ic wild

her#s. hey run a very real ris of !oisonin themselves if they don4t

correctly identify the her#7 or if they use the wron !art of the !lant.

$edication interactionsL *er#al treatments can interact with

medications. +early all her#s come with some warnin7 and many7 lie

the her#s used for an6ietysuch as %alerian and 't. Hohn4s ort7 can

interact with !rescri!tion medication lie antide!ressants. It4s

im!ortant to discuss your medications and her#al su!!lements with

your doctor to avoid danerous interactions.

ac of reulationL Because her#al !roducts are not tihtly reulated7

consumers also run the ris of #uyin inferior :uality her#s. he

:uality of her#al !roducts may vary amon #atches7 #rands or

manufacturers. his can mae it much more difficult to !rescri#e the

!ro!er dose of an her#.

2. $erbal Cosmetic Prodcts

*er#al Cosmetics7 referred as Products7 are formulated7 usin various

!ermissi#le cosmetic inredients to form the #ase in which one or more

her#al inredients are used to !rovide defined cosmetic #enefits only7 shall

13
http://herbs.lovetoknow.com/Herbs_for_Anxietyhttp://herbs.lovetoknow.com/Herbs_for_Anxietyhttp://herbs.lovetoknow.com/Herbs_for_Anxiety


14/52


15/52

1)


16/52

concern with individual coal tar a color ?whether !roduced from coal tar or

synthetically@ is they can cause cancer 1&Q. But natural colors that are

o#tained from her#s are safer.

4) 0ide selection to c5oose from

+atural cosmetics may still #e a new ty!e in the #eauty industry #ut they

already offer a variety of #eauty !roducts for all mae u! cra(y !eo!le out

there to choose from. One will find a variety of foundation7 eye shadow7

li!stic7 #lush7 mascara7 concealer and many more which are all naturally

formulated. urthermore7 one will find locally made natural cosmetics or

those made #y famous desiners worldwide. here e6ist a lare variety of

her#al e6tracts7 to name a few Androra!hisPaniculata ?Falmeh@7

As!araus 2acemosus ?'hatawari@7 Boswellia'errata ?'alai/ual@7

As!halt ?'hila=it@ etc 1,Q.

5) =its yor bdget

+atural cosmetics are not that e6!ensive. In fact7 some of these !roducts

are more afforda#le than synthetic ones. hey are offered at discounted

!rices and are sold for a chea! !rice durin sales. Hust need to survey

enouh to loo for reat deals. An estimate of *O demonstrates a#out

9;< of world !o!ulation de!ends on natural !roducts for their health care7

#ecause of side effects inflicted and risin cost of modern medicine. orld

*ealth Orani(ation currently recommends and encouraes traditional

her#al cures in natural health care !rorams as these drus are easily

availa#le at low cost and are com!aratively safe 1-Q.

6)


17/52

7)


18/52

Fo,oba oil&It is a mi6ture of lon chain7 linear li:uid wa6 esters

e6tracted from the seeds of the desert shru# simmondsiachinenesis7

family simmondsiaceae. Ho=o#a oil is easily refined to remove any

odor7 color it is o6idative sta#le7 and is often used in cosmetics as amoisturi(er and as a carrier oil for e6otic frarances. *uman se#um

and =o=o#a oil are virtually identical. 'e#um !rotects and moisturi(es

the sin and hair #ut is stri!!ed away #y chemicals7 !ollutants7 sun and

the ain !rocess7 resultin in dry sin and hair. Ho=o#a oil re!lenishes

what sin and hair lose and restores them to their natural !* #alance.

1li!e oil&his oil is a fi6ed oil e6tracted from the fruits of

oleaeuro!aea7 family oleaceae. he ma=or constituents are triolein7

tri!almitin7 trilinolein7 tristearate7 monosterate7 triarachidin7 s:ualene7

T5sitosterol and toco!herol. It is used as sin and hair conditioner in

cosmetics lie lotions7 sham!oos etc. It is a !otent fatty acid

!enetration enhancer.

Aloe!era&Aloevera is aher#al !lant s!ecies #elonin to liliaceae

family that is found only in cultivation7 havin no naturally occurrin

!o!ulations7 althouh closely related aloes do have !resence in

northern Africa 9Q. It is an inredient in many cosmetics #ecause it

heals7 moisturi(es7 and softens sin. 'im!ly cut one of the aloe vera

leaves to e6tract the soothin el &Q. Aloe vera contains amino acids

lie leucine7 isoleucine7 sa!onin lycosides that !rovide cleansin

action7 vitamins A7C7E7B7 choline7 B1 and folic acid and !rovide

antio6idant activity.

2) Antiaging

Carrot&It is o#tained from the !lant Daucuscarota#elonin to family

A!iaceae. It is a valua#le her# since aes as due to its richness in

%itamin A alon with other essential vitamins. Carrot seed oil is used

as anti5ain7 revitali(in and re=uvenatin aent &Q. he carrot ets

its characteristic and #riht orane colour from T5carotene7 and lesser

18


19/52

amounts of U5carotene and V5carotene. U and T5carotenes are !artly

meta#oli(ed into vitamin Ain humans.

:ingko&In China and Ha!an7 the leaves and nuts of the /ino#ilo#a?/. #ilo#a@ tree have #een used for thousands of years to treat

various medical conditions7 includin !oor #lood circulationN

hy!ertensionN !oor memory7 and de!ression7 !articularly amon the

elderlyN male im!otence. In addition7 it is ainin a similar re!utation

as an antio6idant and anti5inflammatory aent. /ino #ilo#a#elons

to family /inoaceae7 which rows to a hue si(e 3;Q. he /.

#ilo#ae6tractE/# 0-17 !re!ared from the tree4s leaves7 is a natural

mi6ture containin flavone lycosides ?33


20/52


21/52


22/52

?E. cinerea . $uell.7 E. #aueriana . $uell.7 E. smithii 2. . Baer7 E.

#ridesiana 2. . Baer7 E. microtheca . $uell.7 E. foecunda'chau.7

E. !ulverulenta 'ims7 E. !ro!in:ua Deane and $aiden7 E. erythrocorys

. $uell.@ etc. hey are widely used in the !re!aration of liniments7

inhalants7 couh syru!s7 ointments7 tooth!aste and also as

!harmaceutical flavors. he Euro!ean Pharmaco!oeia monora!h for

Eucaly!tus oil s!orts a chromatora!hic !rofileL 1795cineole

?eucaly!tolN not less than0;


23/52

#y scavenin li!id !ero6yl radicals7 hence !rotectin the cell

mem#rane from destruction.

I.


24/52

'im!ly7 +utraceuticals means7 +>2II%E X P*A2$ACE>ICAL A

food stuff ?as a fortified food or dietary su!!lement@ that !rovides health

#enefits.

he functional food conce!t can #e defined as Jood !roducts to #e taen

as !art of the usual diet in order to have #eneficial effects that o #eyond

#asic nutritional functionK

$ealt5 8enefits

Avoid the side effect.

$ay increase the health #eneficial effect.

$ay have naturally dietary su!!lement7 so do not have un!leasant side

effect.

$ay increase the health value7 our diet and im!rove medical condition

of human.

$ay easily #e availa#le and economically afforda#le.

+utritional thera!y is a healin system usin dietary thera!eutics or

nutraceuticals as a com!lementary thera!y. his thera!y is #ased on the

#elief that foods can not only #e sources of nutrients and enery #ut could

also !rovide medicinal #enefits.

Accordin to nutraceutical and nutritional thera!y theory7 it achieves this

oal #y usin efficacy of such nutraceuticals in deto6ifyin the #ody7avoidin vitamin and mineral deficiencies7 and restorin healthy diestion

and dietary ha#it. Phytonutrients #asically is !lant nutrients with !articular

#ioloical activities in su!!ortin human health.

he !hytochemical wor #y followin wayL

1. 'u#strate for #iochemical reactions.

2. Cofactors of en(ymatic reactions.

3. Inhi#itors of en(ymatic reactions.

24


25/52

4. A#sor#ents that #ind to and eliminate undesira#le constituent in the

intestine.

5. Enhance the a#sor!tion and)or sta#ility of essential nutrients.

6. 'elective rowth factor for #eneficial #acteria.

7. ermentation su#strate for #eneficial #acteria.

8. 'elective inhi#itors of deleterious intestinal #acteria.

9. 'caveners of reactive or to6ic chemicals.

10.iands that aoni(e or antaoni(e cell surface or intracellular

rece!tors.

Classification

+utraceuticals or functional foods can #e classified on the #asis of their

natural sources7 !harmacoloical conditions7 or as !er chemical

constitution of the !roducts.

1. On the #asis of natural source7 it can #e classified as the !roducts

o#tained from !lants7 animals7 minerals7 or micro#ial sources.

2. +utraceuticals as !er the chemical rou!ins.

Category of


26/52

'ome of the most common ways of classifyin nutraceuticals can #e #ased

on food sources7 mechanism of action7 chemical nature7 etc. he food

sources used as nutraceuticals are all natural and can #e cateori(ed as

1. Dietary i#er.2. Pro#iotics.

3. Pre#iotics.

4. Polyunsaturated fatty acids.

5. Antio6idant vitamins.

6. Poly!henols.

7. '!ices

+utraceutical can #e #roadly classified into the followin rou!sL

i@ Potential nutraceuticals.

ii@ Esta#lished nutraceuticals.

A !otential nutraceutical could #ecome an esta#lished one only after

efficient clinical data of its health and medical #enefits are o#tained.

Global Demand of Nutraceutical

he nutraceutical industry lies under three main sements which include

functional foods7 dietary su!!lements7 and her#al)natural !roducts. /lo#al

nutraceutical maret is estimated as >'D 110 #illion ?I+2 ,1&9 #illion@.

In ;;07 nutraceuticals sale is !ro=ected to reach 80&.0 #illion at an AA/2

of "."


27/52

As a conce!t7 J+utraceuticalsK is still in its stae of infancy in India. But it

has #een rowin much faster than lo#al rates at CA/2 of 19< for the

last 3 years driven #y functional food and #everaes cateories. he most

ra!idly rowin sements of the industry were dietary su!!lements ?1".,

!ercent !er year@ and natural)her#al !roducts ?11.- !ercent !er year@.

%eglations

A food stuff ?as a fortified food or a dietary su!!lement@ that !rovides

health #enefits7 if indeed a claim was made that im!lied medicinal #enefit

reardin a nutraceutical !roduct7 the !roduct would #e re:uired to com!ly

with the reulatory re:uirements for medicinal !roducts7 in res!ect of

safety7 efficacy7 and :uality testin and maretin authori(ation

!rocedures. or decades7 DA reulated dietary su!!lements as foods to

ensure that they were safe and wholesome and that their la#elin was

truthful and not misleadin. In ;;-7 the Indian overnment !assed ood

'afety and 'tandard Act to interate and streamline the many reulations

coverin nutraceuticals7 foods7 and dietary su!!lements. he act calls for

the creation of the ood 'afety and 'tandards Authority ?''A@.

8enefits of 'mplementation of =""A' Acts

>nification of eiht laws7 i.e. ste!s to *armoni(ation.

Alinment of international reulations.

'cience5#ased standards.

Clarity and uniformity on novel food areas.

*el! cur# corru!tions.

>nlie the >'7 where the D'*EA is in !lace to reulate these !roducts7 in

India the /overnment is in the !rocess of draftin a law to reulate

manufacturin7 im!ortin7 and maretin of health foods7 dietary

su!!lements7 and other nutraceuticals and finally Indian food safety

standard #ill ;;, sined into law7 !romisin a ma=or im!act on Indian

27


28/52

food !rocessin industry. he Indian ood 'afety and 'tandard Act came

into enforcement in ;;- with the followin two main o#=ectivesL

o introduce a sinle statute relatin to food7 and

o !rovide for scientific develo!ment of the food !rocessin ;;"industry.

:o!ernment %eglations B


29/52

Develo! and manufacture new her#al !roducts or su!!lements in your

#rand and !acain.

4anfactring =acility

he com!any is head:uartered at Indore ?$P@ and has /$P a!!roved

manufacturin facility in Industrial area of Pit5ampr Dist. D5ar alon

with I'O ";;1 accreditation. It is a#out 3, Fm from the cor!orate office

located at Indore. he facility already has /$P and I'O ";;1

accreditation and will have *O5/$P accreditation shortly #y the end of

Han ;1,. It is servin as a contract manufacturer for a num#er of re!uted!harmaceutical com!anies in India. he com!any has #een successful

audited and a!!roved #y the ma=or Indian Com!anies7 namin fewL

a. 4anfactring %ange

4akin aboratories P!t. td. is e:ui!!ed with the most modern

state5of5the5art !lant to manufacture thera!eutic dosae forms lieL

a#lets

Ca!sules

i:uids

Oils

o!icals Ointments and /els

Powders

1r 4anfactring Policy

2aw materials ) *er#al E6tracts used in the manufacturin of

!roducts are from authentic and re!uted sources7 of !rescri#ed :uality

and are free from any contamination

29


30/52

he manufacturin !rocess com!lies with 'OPs as !rescri#ed to

maintain the standards

Ade:uate :uality control measures are ado!ted. Zuality control

measures includin IPZC are strinent. he manufactured !roducts released for sale are of hihest

international :uality.

#. Gality Control and Gality Assrance

e #elieve in total :uality manaement and total :uality com!liance7

we !rovide validation throuh inde!endent la#oratory testin also.

1r 4anfactring Process

30


31/52

Gality 4anagement "ystem

Gality Policy&Our :uality !olicy is to ensure that the :uality of the !roduct

is to satisfy the customer and society accordin to the current ood la#oratory

and manufacturin !ractices.

Gality 1b,ecti!es&o achieve the desired :uality of the !roduct7 the :uality

o#=ectives areL

o manufacture the !roduct remem#erin the re:uirements of

the customer and society. o achieve the :uality with current ood manufacturin and

la#oratory !ractices. o maintain the wor !lace and environment neat and clean.

o a!!ly the corrective chanes for im!lementin the system.

Gality Control

1. 2aw materialsL he first ste! in maintainin :uality is careful selection of

the materials to #e used. $aterials should #e of the same :uality as the sam!le

that was sent to the #uyer. If the same materials are unavaila#le or need to #e

su#stituted7 the #uyer must #e notified. All materials should also #e e6amined

for :uality. ood should #e !ro!erly dried or final !roducts will crac.e6tiles should #e checed for color fastness and shrinin. ittins and

fasteners should function !ro!erly and withstand use. All materials used

should #e consistent in :uality and color. In eneral7 it is not a ood idea to

com!romise :uality for cost #y usin ine6!ensive7 #ut !oorly made materials.

Payin a little more for ood :uality materials will !ay off in the lon run #y

#uildin #uyers confidence in your !roducts.

31


32/52

. Production ProcessL our order must match the sam!le a!!roved #y the

#uyer. o assure this7 it is essential to maintain counter sam!les of the sam!le

sent to the #uyer. his will avoid confusion of what the #uyer is e6!ectin.

Production of the order should #e com!ared to the counter sam!le several

times durin the !roduction !rocess7 not =ust once the !roduct is finished.

'ome #uyers may re:uest that a !roduction sam!le ?!hoto or actual !roduct@

#e sent to them for their a!!roval to assure that matches their s!ecifications

#efore it is shi!!ed. Zuality control throuhout !roduction can hel! identify

mistaes and correct them #efore they result in costly errors. >se a

thorouh:uality control chec listfor monitorin consistency and :uality of

your !roduction.

3. rainin of artisansL *andcrafts are often made in small worsho!s7 and

lare orders may #e filled #y a num#er of different !roducers. In this case7

e6tra care must #e taen to mae sure that the final !roducts are all alie and

are the same as the sam!le. rainin and ood communication with the

artisans is essential. Artisans should understand what is involved in !roducin

crafts for e6!ort and how to meet :uality re:uirements. All artisans should #e

trained in how to chec for :uality issues as they mae the !roducts and #e

!rovided with a chec list of what to loo for when monitorin the :uality of

their !roduction.

&. orin conditionsL /ood :uality is also a factor of the worin conditions

of the artisans. orin conditions include thins lie fair waes7 !ro!er wor

areas and e:ui!ment7 and worer incentives. he !rice !aid to the artisan can

im!act the :uality of !roduction7 as does the time they have to fulfill an order.

If artisans have to !roduce a lare order in a short amount of time7 this could

result in :uality #ein com!romised. If artisans are !aid a low wae7 they have

little incentive to invest time into main a ood :uality item. Artisans also

need to have access to funds to !urchase raw materials of the :uality desired.

'ome artisan orani(ations have develo!ed a savins and loan !roram7 to

lend money to artisans for the !urchase of raw materials when they need it.

$ost fair trade orani(ations should offer !re5financin when !lacin an

32
http://serrvartisans.files.wordpress.com/2012/03/quality-control-checklist.pdfhttp://serrvartisans.files.wordpress.com/2012/03/quality-control-checklist.pdf


33/52

order7 to assure that artisans can cover the costs of !urchasin materials and

!roducin the !roducts. inally7 ood :uality !roduction also de!ends on

worsho! conditions. or areas should #e e!t clean and artisans should

have the minimal tools needed. 'ometimes somethin as sim!le as main

sure the artisans have ta!e measurers can mae a #i difference.

,. Pro!er !acinL Zuality can also #e com!romised if !roducts are not

!ro!erly !aced for shi!!in. A !roduct may have #een made well7 #ut #e

damaed durin shi!!in7 resultin in losses. Entire #o6es of !roducts can

arrive damaed #ecause they were !aced when still wet7 were !aced too

tihtly or without ade:uate !rotection. Zuality control also includes !acin

!roducts so that they are !rotected from damaes until they reach the #uyer.

Pro!er !acin is the res!onsi#ility of the !roducer. or more on !acin7 see

the Pacin and Pacain section.

Effective Zuality Control

$aintain counter sam!le oriinals of the same :uality sam!le sent to#uyer.

Chec :uality control at multi!le !oints throuhout !roduction

!rocess.

>se a thorouh :uality control chec list for monitorin consistency

and :uality of your !roduction.

Provide chec list for all staes of !roduction and mae sure all

artisans now how to chec for :uality issues as they mae the!roducts.

33


34/52

Gality Assrance Process 7 Procedres

$eetin customer e6!ectations comes from consistently meetin standards.

our com!any is only as ood as its last customer e6!erience. If your

em!loyees do not meet your standard7 your !atrons may see out the

com!etition the ne6t time a need arises. Deliverin consistent results is at the

core of :uality assurance !rocedures. hether you are manufacturin a

million widets or fi6in com!uters for local clients7 every em!loyee needs to

now the com!any4s :uality standards and how to achieve them.

T5e "5ew5art Cycle

o deliver !roducts and services with consistent results7 you can

im!lement the 'hewhart Cycle7 which uses four ste!sL Plan7 Do7 Chec

and Act ?PDCA@. In the Plan ste!7 state the desired oals for your !roduct

and how they will #e achieved. he Do ste! is your im!lementation of the

!lan. Once the !roduct is in !roduction7 it is time to Chec to mae sure it

is meetin the standard you set in the Plan ste!. Act re:uires you and your

team to mae necessary corrections when the !roduct is not meetin the

correct standards.

34


35/52

Defining Gality

Zuality assurance relies on a strict definition of what is acce!ta#le and not

acce!ta#le from a !roduct or service. If a customer has ordered a widet

from your com!any that is to #e cut into three5inch !ieces7 then a four5inch

!iece does not meet the :uality standard. A cleanin service may have a

standard that calls for #athroom mirrors to #e cleaned free of smudesN a

finer!rint left #ehind falls outside of the standard.

It is your res!onsi#ility to your com!any4s success to mae sure that every

em!loyee understands the :uality definitions and how he is to maecertain those standards are met.

4easring Gality

$easurin the :uality that is delivered is critical for consistent results.

$anaers and su!ervisors should chec an em!loyee4s wor as it relates to

:uality standards. hen :uality falls short7 su!ervisors are res!onsi#le for

main the chane re:uired to #rin :uality #ac to the !ro!er standard.

'mpro!ing Gality

he old e6!ression7 Mhere is always room for im!rovement7M rins true

when it comes to :uality assurance. o ee! your #usiness on the cuttin

ede7 you should always #e asin the :uestion7 M*ow can we mae this

#etter[M By tweain the !rocess here and there or #y raisin standards a

small #it each year7 you will see your overall #usiness :uality im!rove to

levels reater than you ever imained.

35


36/52

"trctre of t5e 1rganiation

36


37/52

1r Clients

:lenmark P5arma

37


38/52

Alkem P5arma

Emcre

opran

38


39/52

pin

4icro abs td.

Troikaa P5arma

39


40/52

TT $ealt5care

?nic5em aboratories td.

'ntrodction to Pro,ect

he Pharmaceutical industry is a dynamic industry7 with new !roducts are

launched every three months. he #usiness develo!ment division of the

com!any acts as the first interface to the e6istin and the !ros!ective clients.

As intern in a Business develo!ment division of this com!any my

res!onsi#ilities were.

1. Act as liaison #etween e6istin clients and manufacturin

facility.

. Pros!ect :ualifyin and Consultative sales.

3. $anain relationshi! with e6istin clients7 Client retention.

&. Clientele e6tension.

,. 2P)2I)Bid !re!aration

-. Contract and deal neotiation and closin.

0. 'ales manaement

40


41/52

1b,ecti!e of t5e "tdy

1. Academic O#=ectiveL 'u#mission of internshi! re!ort to fulfill

deree com!letion re:uirements.

. Fnowlede O#=ectiveL o understand !ractical im!lications oftheoretical conce!ts of #usiness develo!ment activities

4a,or earning

%1E D'4E


42/52

o !lan and diari(e reular contact with !ros!ective clients in order to

maintain relationshi! and ain information a#out their oals and

o#=ectives and com!etitive activities.

o #e aware of de!artmental worloads and manae client e6!ectationsaccordinly.

'nterpersonal "kills

o effectively sell in the heads #rand services to clients to ain

commitment to tender for #usiness.

o form relationshi!s with ey !ersonals in the client com!anies.

o understand clients relationshi!s such that ey information re:uired

for :ualifyin the o!!ortunity is o#tained early on.

o trac and review with BD Director !ersonal develo!ment o#=ectives

to #uild sellin sills.

Teamwork

o wor across #usiness manain relationshi!s with other

de!artments at all staes of the sales !rocess.

o wor with other areas of #usiness ensurin necessary lead times are

understood in order to deliver a :uality !ro!osal.

o hel! other de!artments achieve their oals at all times and

es!ecially durin !ea worload.

o hold half yearly and annual a!!raisals with manaement to identify

!erformance achievement7 !ersonal oals and develo!ment oals.

Commnication

o ensure that all communication with !ros!ective clients is focused

and a!!ro!riate for their #usiness sector.

42


43/52

o !re!are client #riefs and #rief other de!artments effectively ?new

and e6istin clients@.

o !rovide feed#ac to de!artments on interim desins and costs such

that client needs are met. o !re!are and !resent hih :uality client !ro!osals in a clear7

structured and customer focused format.

o !rovide client feed#ac to all de!artment heads in a !ositive and

constructive way on wins)losses.

o maintain sills in the use of tools for the role e.. 'ae7 s!read

sheets7 document !re!aration.

:eneral

o ensure that all administrative !rocesses and !rocedures are adhered

to and com!leted in a timely manner.

o o!erate within allotted #udetary !arameters e.. with travel and

attendance at shows.

o understand and ado!t safe worin !ractices.

o adhere to all com!any !olicies and uidelines as sti!ulated in

contract of em!loyment.

Personal Galities

o !ro=ect a smart and !rofessional imae at all times.

o #e !roactive in all as!ects of the =o# role.

Be res!onsi#le for own self5develo!ment7 es!ecially ee!in a#reast of

current ha!!enins.

%ele!ant "kills> nowledge and Experience

$inimum 35, years e6hi#ition e6!erience within #usiness

develo!ment role or e:uivalent telesales environment

/ood communication7 !resentation G inter!ersonal sills.

A#ility to influence and ain areement of !ros!ective clients

/ood Plannin G oranisational sills

43


44/52

/ood written and ver#al communication sills

'elf5$otivated and hard worin.

Annual7 Zuarterly and $onthly O#=ectives will #e set #y the Business

Develo!ment Director and reviewed reularly aainst !erformance

measures detailed aainst the o#=ectives.

A#ility to lead a team creatively7 nurturin team mem#ers.

/ood analytical sills com#ined with a#ility to reconise and

im!lement !lans.

E6cellent !lannin G oranisational sills.

E6cellent technical G creative sills.

$ow 8siness De!elopment takes place in t5e manfactring nit

of P5armacetical Company

Business development is the creation of long-

term value for an organization from customers,

markets, and relationships.

8siness de!elopment?BD@ com!rises a num#er of tass and !rocesses

enerally aimin at develo!in and im!lementin rowth o!!ortunities within

and #etween orani(ations. It is a su#set of the fields of #usiness7 commerce

andorani(ational theory. Business develo!ment is the creation of lon5term

value for an orani(ation from customers7 marets7 andrelationshi!s.

44
https://en.wikipedia.org/wiki/Organizational_theoryhttps://en.wikipedia.org/wiki/Marketshttps://en.wikipedia.org/wiki/Interpersonal_relationshiphttps://en.wikipedia.org/wiki/Organizational_theoryhttps://en.wikipedia.org/wiki/Marketshttps://en.wikipedia.org/wiki/Interpersonal_relationship


45/52

he #usiness develo!er is concerned with the analytical !re!aration of

!otential rowth o!!ortunities for the senior manaementor#oard of

directorsas well as the su#se:uent su!!ort and monitorin of its

im!lementation. Both in the develo!ment !hase and the im!lementation

!hase7 the #usiness develo!er colla#orates and interates the nowlede and

feed#ac from the orani(ations s!ecialist functions. E6am!les are 2GD7

!roduction7 maretin7 and sales to assure that the orani(ation is ca!a#le of

im!lementin the rowth o!!ortunities successfully. he #usiness develo!ers4

tools to address the #usiness develo!ment tass are the#usiness model of

continuous evaluation of #usiness o#=ectives.

Business develo!ment!rofessionalsfre:uently have had earlier e6!erience in

sales7 financial services7 investment #anin or manaement consultinN

althouh some find their route to this area #y clim#in the cor!orate ladder in

functions such as o!erations manaement. 'ill setand e6!erience for

#usiness5develo!ment s!ecialists usually consist of a mi6ture of the followin

?de!endin on the #usiness re:uirements@L

'ales

inance

$aretin

$erers and ac:uisitions

eal

'trateic manaement

Pro!osal manaement or ca!ture manaement

he M!i!elineMrefers to flow of !otential clients which a com!any has started

develo!in. Business5develo!ment staff assined to each !otential client in the

!i!eline with o#=ective of convertin !ros!ect into a successful client7 with

!ro=ected sales5volumes attached. Planners can use the weihted averaeof all

the !otential clients in the !i!eline to !ro=ect staffin to manae the new

activity when finali(ed. Enter!rises usually su!!ort !i!elines with some ind

of customer relationshi! manaement?C2$@ tool or C2$5data#ase7either

we#5#ased solution or an in5house system. 'ometimes #usiness develo!ment

45
https://en.wikipedia.org/wiki/Senior_managementhttps://en.wikipedia.org/wiki/Board_of_directorshttps://en.wikipedia.org/wiki/Board_of_directorshttps://en.wikipedia.org/wiki/Outline_of_industrial_organizationhttps://en.wikipedia.org/wiki/Marketing_managementhttps://en.wikipedia.org/wiki/Sales_managementhttps://en.wikipedia.org/wiki/Business_modelhttps://en.wikipedia.org/wiki/Professionalhttps://en.wikipedia.org/wiki/Financial_serviceshttps://en.wikipedia.org/wiki/Investment_bankinghttps://en.wikipedia.org/wiki/Management_consultinghttps://en.wikipedia.org/wiki/Operations_managementhttps://en.wikipedia.org/w/index.php?title=Skill_set&action=edit&redlink=1https://en.wikipedia.org/wiki/Financehttps://en.wikipedia.org/wiki/Marketinghttps://en.wikipedia.org/wiki/Mergers_and_acquisitionshttps://en.wikipedia.org/wiki/Strategic_managementhttps://en.wikipedia.org/wiki/Sales_pipelinehttps://en.wikipedia.org/wiki/Weighted_averagehttps://en.wikipedia.org/wiki/Customer_relationship_managementhttps://en.wikipedia.org/wiki/Databasehttps://en.wikipedia.org/wiki/Systemhttps://en.wikipedia.org/wiki/Senior_managementhttps://en.wikipedia.org/wiki/Board_of_directorshttps://en.wikipedia.org/wiki/Board_of_directorshttps://en.wikipedia.org/wiki/Outline_of_industrial_organizationhttps://en.wikipedia.org/wiki/Marketing_managementhttps://en.wikipedia.org/wiki/Sales_managementhttps://en.wikipedia.org/wiki/Business_modelhttps://en.wikipedia.org/wiki/Professionalhttps://en.wikipedia.org/wiki/Financial_serviceshttps://en.wikipedia.org/wiki/Investment_bankinghttps://en.wikipedia.org/wiki/Management_consultinghttps://en.wikipedia.org/wiki/Operations_managementhttps://en.wikipedia.org/w/index.php?title=Skill_set&action=edit&redlink=1https://en.wikipedia.org/wiki/Financehttps://en.wikipedia.org/wiki/Marketinghttps://en.wikipedia.org/wiki/Mergers_and_acquisitionshttps://en.wikipedia.org/wiki/Strategic_managementhttps://en.wikipedia.org/wiki/Sales_pipelinehttps://en.wikipedia.org/wiki/Weighted_averagehttps://en.wikipedia.org/wiki/Customer_relationship_managementhttps://en.wikipedia.org/wiki/Databasehttps://en.wikipedia.org/wiki/System


46/52

s!ecialists manae and analy(e the data to !roduce salesmanaement

information?$I@. 'uch $I could includeL

reasons for wins)losses

!roress of o!!ortunities in relation to the sales !rocess

to! !erformin sales !eo!le)sales channels

sales of services)!roducts

or larer and well5esta#lished com!anies7 es!ecially in technoloy5related

industries7 the term M#usiness develo!mentM often refers to settin u! and

manain strateic relationshi!s andallianceswith other7 third5!arty

com!anies. In these instances the com!anies may leverae each

other4se6!ertise7 technoloiesor other intellectual !ro!ertyto e6!and their

ca!acities for identifyin7 researchin7 analy(in and #rinin to maret new

#usinesses and new !roducts. Business5develo!ment focuses on

im!lementation of the strateic #usiness !lan throuh e:uity financin7

ac:uisition)divestiture of technoloies7 !roducts7 and com!anies7 !lus the

esta#lishment of strateic !artnershi!s where a!!ro!riate.

"01T Analysis

he 'O analysis of the industry reveals the !osition of the Indian

!harmaceutical industry in res!ect to its internal and e6ternal environment.

a) "trengt5s

*iher /DP rowth leadin to increased dis!osa#le income in the hands

of eneral !u#lic and their !ositive attitude towards s!endin on healthcare.

46
https://en.wikipedia.org/wiki/Management_information_systemhttps://en.wikipedia.org/wiki/Management_information_systemhttps://en.wikipedia.org/wiki/Strategic_alliancehttps://en.wikipedia.org/wiki/Expertisehttps://en.wikipedia.org/wiki/Technologieshttps://en.wikipedia.org/wiki/Intellectual_propertyhttps://en.wikipedia.org/wiki/Management_information_systemhttps://en.wikipedia.org/wiki/Management_information_systemhttps://en.wikipedia.org/wiki/Strategic_alliancehttps://en.wikipedia.org/wiki/Expertisehttps://en.wikipedia.org/wiki/Technologieshttps://en.wikipedia.org/wiki/Intellectual_property


47/52

ow5cost7 hihly silled set of Enlish s!eain la#or force and !roven

trac record in desin of hih technoloy manufacturin devices.

/rowin treatment naive !atient !o!ulation.

ow cost of innovation7 manufacturin and o!erations.

b) 0eaknesses

'trinent !ricin reulations affectin the !rofita#ility of !harma

com!anies.

Poor all5round infrastructure is a ma=or challene.

Presence of more unorani(ed !layers versus the orani(ed ones7 resultin

in an increasinly com!etitive environment7 characteri(ed #y stiff !rice

com!etition.

Poor health insurance coverae.

c) 1pportnities

/lo#al demand for enerics risin.

2a!id OC and eneric maret rowth.

Increased !enetration in the non 5 metro marets.

are demand for :uality dianostic services.

'inificant investment from $+Cs.

Pu#lic5Private Partnershi!s for strenthenin Infrastructure.

O!enin of the health insurance sector and increase in !er ca!ita income 5

the rowth drivers for the !harmaceutical industry.

India7 a !otentially !referred lo#al outsourcin hu# for !harmaceutical!roducts due to low cost of silled la#or.

d) T5reats

ae inflation.

/overnment e6!andin the um#rella of the Drus Price Control Order

?DPCO@.

47


48/52

Other low5cost countries such as China and Israel affectin outsourcin

demand for Indian !harmaceutical !roducts

Entry of forein !layers ?well5e:ui!!ed technoloy5#ased !roducts@ into

the Indian maret.

4a,or C5allenges =aced 8y t5e 'ndstry

he Indian !harmaceutical industry was on a stron rowth tra=ectory in the

last decade. It has achieved several milestones and is well !ositioned to

leverae emerin o!!ortunities. *owever7 the industry needs to tacle

various issues related to its o!erations and reulations. It faces several

challenes in the form of !ricin of !harmaceutical !roducts and im!act of

some areements. his section touches u!on several ey issues and challenes

faced #y the industryL

48


49/52

'mpact of :ATTBT%'P" agreement&he /eneral Areement on

ariffs and rade1 ?/A@ and rade 2elated as!ects of Intellectual

Pro!erty 2ihts ?2IP'@ have an adverse im!act on !ricin of

!harmaceutical !roducts. Pharmaceutical com!anies are not allowed to

re5enerate e6istin drus and formulations and chane the e6istin

!rocess and manufacture the same dru. +ew investments are re:uired

to !erform research. his is a ma=or o#stacle for !harma com!anies7

es!ecially the micro7 small and medium enter!rises. $oreover7 transfer

of technoloy from a#road is difficult and e6!ensive. Conse:uently7

revenue of the !harma com!anies is im!acted. *ence7 ade:uate

measures should #e taen to su!!ort the industrys revenue and

minimi(e losses.

Pricing&At !resent7 !ricin of 0& #ul drus and their formulations7

which account for a lare share in the retail !harma maret7 are

controlled #y the Dru Price Control Order ?DPCO@51"",. he

/overnment had considered reducin the num#er of reulated drus7

#ut it has not #een im!lemented. here is a need to reduce the num#er

of reulated drus to facilitate the rowth of the !harmaceutical

industry.

Drg di!ersions by instittions&$ost of the institutional clients of

the Indian !harmaceutical com!anies com!rise overnment hos!itals7

the Indian defense service and !rivate hos!italsN the defense sector is

mandated to #uy dru stocs throuh tenders in :uantities twice as

lare as the !ro=ected demand for those drus in the followin year at a

discounted !rice. At the year5end7 sur!lus availa#le at the institutions is

!ushed to reular channels #y leverain the !rice discounts7 resultin

in a loss for com!anies throuh the reular distri#ution channel.

49


50/52

8'8'1:%AP$@

$ain a#oratories Private imited is a Private Com!any incor!orated on "A!ril 1"90. It is classified as Indian +on5/overnment Com!any and is

reistered at 2eistrar of Com!anies7 /walior. Its authori(ed share ca!ital is

2s. 07,;;7;;; and its !aid u! ca!ital is 2s. ,7"9;7;;;.It is involved in

%eterinary activities.

50


51/52

!akin Laboratories "rivate Limite#s $nn%al General !eeting $G!' was

last hel on () *eptember +), an as per recors from !inistry of

Corporate $ffairs !C$'.

Company Information

,om!an# -ame &/=I- >/?/TI$ I@/T

>I&IT%

o, o,;walior

eistration -um"er 3930

/cti(it# @eterinar# acti(ities Aincludin

clinico;!atholoical and other

dianostic acti(ities !ertainin

to animals and "irdsB.

,om!an# ,ateor# ,om!an# limited "# shares

,om!an# $u" ,ateor# Indian -on;o(ernment

,om!an#

,lass of ,om!an# ri(ate ,om!an#

/uthoriCed ,a!ital )in s.+ 7'500'000

aid u! ca!ital )in s.+ 5'980'000

-um"er of

&em"ers)/!!lica"le onl# in

case of com!an# without

$hare ,a!ital+

;

%ate of Incor!oration 29 /!ril 1987

mail I% manassociatesDmail.com

/ddress 1 lot no 48' $ector III

/ddress 2 itham!ur

51


52/52

,it# I-%

$tate &adh#a radesh

,ountr# I-%I/

I- 454774

Ehether listed or not Fnlisted

%ate of >ast /& 30 $e!tem"er 2014

Date post:	11-Feb-2018
Category:	Documents
Upload:	er-akhilesh-singh
View:	232 times
Download:	0 times

Pharmaceutical Industry Report

Documents